HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal injection of triamcinolone acetonide to treat cystoid foveal edema associated with coats' disease.

AbstractPURPOSE:
To investigate the efficacy of intravitreal injection of triamcinolone acetonide (TA) for treatment of cystoid foveal edema (CFE) associated with Coats' disease.
METHODS AND PATIENT:
A 32-year-old man with a 28-month history of Coats' disease received an intravitreal TA injection (4 mg) in the right eye.
RESULTS:
Visual acuity improved from 20/200 to 20/50, and foveal thickness decreased from 701 μm to 216 μm 45 days after treatment.
CONCLUSION:
Intravitreal TA injection might temporarily improve visual acuity in eyes with CFE associated with Coats' disease.
AuthorsTetsushi Kimura, Hitoshi Takagi, Mihori Kita, Daisuke Watanabe, Nagahisa Yoshimura
JournalRetinal cases & brief reports (Retin Cases Brief Rep) Vol. 3 Issue 2 Pg. 167-9 ( 2009) ISSN: 1935-1089 [Print] United States
PMID25391065 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: